Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

ClinicalTrials.gov ID: NCT00895011

Public ClinicalTrials.gov record NCT00895011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy

Study identification

NCT ID
NCT00895011
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
VIVUS LLC
Industry
Enrollment
298 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Avanafil Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Mar 31, 2011
Completion
Mar 31, 2011
Last update posted
Sep 30, 2012

2009 – 2011

United States locations

U.S. sites
51
U.S. states
20
U.S. cities
45
Facility City State ZIP Site status
Research Site Phoenix Arizona 85050
Research Site Laguna Hills California 92653
Research Site Los Angeles California 90073
Research Site Los Angeles California 90095
Research Site Sacramento California 95817
Research Site Aurora Colorado 80045
Research Site Englewood Colorado 80113
Research Site Parker Colorado 80134
Research Site Washington D.C. District of Columbia 20006
Research Site Jacksonville Florida 32224
Research Site Miami Florida 33136
Research Site Trinity Florida 34655
Research Site Chicago Illinois 60611
Research Site Chicago Illinois 60637
Research Site Springfield Illinois 62703
Research Site Indianapolis Indiana 46202
Research Site New Orleans Louisiana 70112
Research Site Shreveport Louisiana 71106
Research Site Baltimore Maryland 21287
Research Site Towson Maryland 21204
Research Site Brighton Massachusetts 02135
Research Site Burlington Massachusetts 01805
Research Site Jamaica Plain Massachusetts 02130
Research Site Ann Arbor Michigan 48109
Research Site Hackensack New Jersey 07601
Research Site Lawrenceville New Jersey 08648
Research Site Brooklyn New York 11215
Research Site Brooklyn New York 11235
Research Site Garden City New York 11530
Research Site Great Neck New York 11021
Research Site New York New York 10016
Research Site New York New York 10029
Research Site New York New York 10065
Research Site Poughkeepsie New York 12601
Research Site Durham North Carolina 27710
Research Site Greensboro North Carolina 27403
Research Site Cincinnati Ohio 45212
Research Site Cleveland Ohio 44195
Research Site Bala-Cynwyd Pennsylvania 19004
Research Site Philadelphia Pennsylvania 19107
Research Site Philadelphia Pennsylvania 19111
Research Site Myrtle Beach South Carolina 29572
Research Site Rock Hill South Carolina 29732
Research Site Nashville Tennessee 37232
Research Site Arlington Texas 76017
Research Site Houston Texas 77030
Research Site San Antonio Texas 78229
Research Site Temple Texas 76508
Research Site Charlottesville Virginia 22908
Research Site Fairfax Virginia 22030
Research Site Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00895011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00895011 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →